Remission of anti-TIF1γ dermatomyositis after allogeneic hematopoietic stem cell transplant for myelodysplastic syndrome

Blood Adv. 2020 Nov 24;4(22):5698-5701. doi: 10.1182/bloodadvances.2020003104.

Abstract

  1. DM, an autoimmune inflammatory myopathy, can be associated with a number of malignancies, including, rarely, myelodysplastic syndromes.

  2. Allo-HCT presents a novel approach to treat refractory DM in patients with a coexisting malignancy through the GvA effect.

MeSH terms

  • Dermatomyositis* / diagnosis
  • Dermatomyositis* / etiology
  • Dermatomyositis* / therapy
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Myelodysplastic Syndromes* / therapy